Smith & Nephew reported strong revenue growth, profitability improvements, and significant cash flow increases, along with a major share buyback announcement. However, challenges remain, particularly in emerging markets, and potential headwinds from U.S. tariffs and reimbursement changes. Overall, the company appears optimistic about sustaining growth and improving margins.

Company Guidance -

Q4 2025

During the Smith & Nephew second quarter and first half results meeting, CEO Deepak Nath and CFO John Rogers provided detailed guidance on the company's performance and future outlook. The company reported a 6.7% underlying revenue growth in the quarter, with a trading margin expansion of 100 basis points in the first half, slightly ahead of expectations. The full-year margin guidance remains between 19% to 20%, despite a $15 million to $20 million headwind from tariffs anticipated in 2025. The company also highlighted a 70% increase in trading cash flow and nearly $250 million in free cash flow for the first half. A $500 million share buyback is planned for the second half, funded by 2025 cash flow and existing balances. Geographically, the U.S. market showed an 8.7% growth, while emerging markets experienced a slight decline of 0.2%, mainly due to volume-based procurement impacts in China. The company's Orthopaedics business grew by 5.5%, with significant advancements in the U.S. Recon and Robotics, marking the fourth consecutive quarter of improvement. Sports Medicine and ENT achieved a 5.7% growth, and Advanced Wound Management increased by 10.2%, driven by a rebound in Bioactives. The company remains focused on operational efficiencies, inventory management, and expanding its innovation pipeline to sustain growth and profitability.

Strong Revenue Growth

Smith & Nephew reported 6.7% underlying revenue growth in the quarter, with all regions and business units showing acceleration. Revenue in the quarter was $1.6 billion.

Profitability Improvements

The company achieved a 100 basis point expansion in trading margin in the first half and remains on track for a full year margin guidance of 19% to 20%.

Significant Cash Flow Increase

Trading cash flow increased by 70%, resulting in almost $250 million of free cash flow in the first half.

Share Buyback Announcement

Smith & Nephew announced a $500 million share buyback in the second half of 2025, fully funded by 2025 cash flow and existing balances.

Orthopaedics Margin Expansion

Orthopaedics margin expanded by 230 basis points in the first half due to transformation initiatives.

Advanced Wound Management Growth

Advanced Wound Management grew by 10.2% due to a rebound in Bioactives.

Smith & Nephew Snats (SNN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

SNN Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Feb 24, 2026	2025 (Q4)	1.16 / -	0.938	―	―	―
Aug 05, 2025	2025 (Q2)	0.86 / 0.86	0.756	13.49% (+0.10)
Feb 25, 2025	2024 (Q4)	0.92 / 0.94	0.958	-2.09% (-0.02)
Aug 01, 2024	2024 (Q2)	0.79 / 0.76	0.7	8.00% (+0.06)
Feb 27, 2024	2023 (Q4)	0.97 / 0.96	0.87	10.11% (+0.09)
Aug 03, 2023	2023 (Q2)	0.73 / 0.70	0.762	-8.14% (-0.06)
Feb 21, 2023	2022 (Q4)	0.73 / 0.87	0.8	8.75% (+0.07)
Jul 28, 2022	2022 (Q2)	0.76 / 0.76	0.776	-1.80% (-0.01)	―	―
Feb 22, 2022	2021 (Q4)	0.87 / 0.80	1.026	-22.03% (-0.23)	―	―
Jul 29, 2021	2021 (Q2)	0.79 / 0.78	0.26	198.46% (+0.52)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

SNN Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 05, 2025	$30.79	$35.48	+15.23%
Feb 25, 2025	$25.87	$27.67	+6.96%
Aug 01, 2024	$28.07	$30.00	+6.88%
Feb 27, 2024	$27.33	$26.78	-2.01%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Smith & Nephew Snats (SNN) report earnings?

Smith & Nephew Snats (SNN) is schdueled to report earning on Feb 24, 2026, Before Open (Confirmed).

What is Smith & Nephew Snats (SNN) earnings time?

Smith & Nephew Snats (SNN) earnings time is at Feb 24, 2026, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is SNN EPS forecast?

SNN EPS forecast for the fiscal quarter 2025 (Q4) is 1.16.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing